These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 7899235)
1. Natriuretic peptide-potentiating actions of neutral endopeptidase inhibition in rats with experimental heart failure. Yasuhara M; Yamaguchi M; Shimizu H; Hashimoto Y; Hama N; Itoh H; Nakao K; Hori R Pharm Res; 1994 Dec; 11(12):1726-30. PubMed ID: 7899235 [TBL] [Abstract][Full Text] [Related]
2. Clearance mechanisms of atrial and brain natriuretic peptides in rats. Hashimoto Y; Nakao K; Hama N; Imura H; Mori S; Yamaguchi M; Yasuhara M; Hori R Pharm Res; 1994 Jan; 11(1):60-4. PubMed ID: 8140057 [TBL] [Abstract][Full Text] [Related]
3. Role of neutral endopeptidase 24.11 in AV fistular rat model of heart failure. Wegner M; Hirth-Dietrich C; Stasch JP Cardiovasc Res; 1996 Jun; 31(6):891-8. PubMed ID: 8759244 [TBL] [Abstract][Full Text] [Related]
4. Neutral endopeptidase inhibition: augmented atrial and brain natriuretic peptide, haemodynamic and natriuretic responses in ovine heart failure. Rademaker MT; Charles CJ; Espiner EA; Nicholls MG; Richards AM; Kosoglou T Clin Sci (Lond); 1996 Sep; 91(3):283-91. PubMed ID: 8869410 [TBL] [Abstract][Full Text] [Related]
5. Acute and chronic neutral endopeptidase inhibition in rats with aortocaval shunt. Willenbrock R; Scheuermann M; Höhnel K; Luft FC; Dietz R Hypertension; 1996 Jun; 27(6):1259-66. PubMed ID: 8641733 [TBL] [Abstract][Full Text] [Related]
6. The role of neutral endopeptidase in dogs with evolving congestive heart failure. Margulies KB; Barclay PL; Burnett JC Circulation; 1995 Apr; 91(7):2036-42. PubMed ID: 7895362 [TBL] [Abstract][Full Text] [Related]
8. Novel analog of atrial natriuretic peptide selective for receptor-A produces increased diuresis and natriuresis in rats. Jin H; Li B; Cunningham B; Tom J; Yang R; Sehl P; Thomas GR; Ko A; Oare D; Lowe DG J Clin Invest; 1996 Aug; 98(4):969-76. PubMed ID: 8770869 [TBL] [Abstract][Full Text] [Related]
10. Nonlinear mixed effect modeling of the pharmacodynamics of natriuretic peptides in rats. Hashimoto Y; Mori S; Hama N; Nakao K; Imura H; Yamaguchi M; Yasuhara M; Hori R J Pharmacokinet Biopharm; 1993 Jun; 21(3):281-97. PubMed ID: 8258768 [TBL] [Abstract][Full Text] [Related]
11. Effect of neutral endopeptidase inhibitor on endogenous atrial natriuretic peptide as a paracrine factor in cultured cardiac fibroblasts. Maki T; Horio T; Yoshihara F; Suga S; Takeo S; Matsuo H; Kangawa K Br J Pharmacol; 2000 Nov; 131(6):1204-10. PubMed ID: 11082129 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and renal effects of iso-rANP, a second natriuretic peptide from rat atria. Jennings DB; Flynn TG Can J Physiol Pharmacol; 1989 Oct; 67(10):1372-9. PubMed ID: 2532951 [TBL] [Abstract][Full Text] [Related]
13. Modification of the renal response to endopeptidase inhibition and atrial natriuretic peptide infusion in normal dogs. Levy M; Cernacek P Can J Physiol Pharmacol; 1992 Dec; 70(12):1563-70. PubMed ID: 1301233 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of ANP clearance receptors and endopeptidase 24.11 in maturing rats. Chevalier RL; Garmey M; Scarborough RM; Linden J; Gomez RA; Peach MJ; Carey RM Am J Physiol; 1991 Jun; 260(6 Pt 2):R1218-28. PubMed ID: 1647702 [TBL] [Abstract][Full Text] [Related]
15. Angiotensin inhibition potentiates the renal responses to neutral endopeptidase inhibition in dogs with congestive heart failure. Margulies KB; Perrella MA; McKinley LJ; Burnett JC J Clin Invest; 1991 Nov; 88(5):1636-42. PubMed ID: 1658047 [TBL] [Abstract][Full Text] [Related]
16. Role of atrial natriuretic peptide in natriuresis in volume-expanded rats. Kaneko K; Okada K; Ishikawa S; Kuzuya T; Saito T Am J Physiol; 1987 Dec; 253(6 Pt 2):R877-82. PubMed ID: 2962511 [TBL] [Abstract][Full Text] [Related]
17. Long-term treatment with neutral endopeptidase inhibitor improves cardiac function and reduces natriuretic peptides in rats with chronic heart failure. Maki T; Nasa Y; Yamaguchi F; Yoshida H; Mori M; Takada T; Horikawa E; Okano K; Takeo S Cardiovasc Res; 2001 Aug; 51(3):608-17. PubMed ID: 11476752 [TBL] [Abstract][Full Text] [Related]
18. Localization and characterization of neutral metalloendopeptidase (EC 3.4.24.11), the degradative enzyme for atrial natriuretic peptide, in rat kidney using a radioiodinated neutral metalloendopeptidase inhibitor. Kanazawa M; Casley DJ; Sybertz EJ; Haslanger MF; Johnston CI J Pharmacol Exp Ther; 1992 Jun; 261(3):1231-7. PubMed ID: 1534841 [TBL] [Abstract][Full Text] [Related]
19. Suppression of atherosclerotic changes in cholesterol-fed rabbits treated with an oral inhibitor of neutral endopeptidase 24.11 (EC 3.4.24.11). Kugiyama K; Sugiyama S; Matsumura T; Ohta Y; Doi H; Yasue H Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):1080-7. PubMed ID: 8696950 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of neutral endopeptidase, the degradative enzyme for natriuretic peptides, in rat kidney after oral SCH 42495. Burrell LM; Farina N; Risvanis J; Woollard D; Casely D; Johnston CI Clin Sci (Lond); 1997 Jul; 93(1):43-50. PubMed ID: 9279202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]